262 related articles for article (PubMed ID: 21862695)
21. Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia.
Gómez R; Abad A; Delgado F; Tamarit S; Simón C; Pellicer A
Fertil Steril; 2011 Mar; 95(3):882-8.e1. PubMed ID: 21055747
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.
Xu H; Zhang T; Man GC; May KE; Becker CM; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wong AW; Wang CC
Angiogenesis; 2013 Jul; 16(3):541-51. PubMed ID: 23334337
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor A and C gene expression in endometriosis.
Takehara M; Ueda M; Yamashita Y; Terai Y; Hung YC; Ueki M
Hum Pathol; 2004 Nov; 35(11):1369-75. PubMed ID: 15668894
[TBL] [Abstract][Full Text] [Related]
24. Time course of pelvic endometriotic lesion revascularization in a nude mouse model.
Eggermont J; Donnez J; Casanas-Roux F; Scholtes H; Van Langendonckt A
Fertil Steril; 2005 Aug; 84(2):492-9. PubMed ID: 16084895
[TBL] [Abstract][Full Text] [Related]
25. Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Meresman GF; Barañao RI
Reprod Sci; 2011 Jul; 18(7):614-22. PubMed ID: 21266664
[TBL] [Abstract][Full Text] [Related]
26. [Human endostatin antiangiogenic gene therapy mediated by recombinant adeno-associated virus vector in nude mouse with endometriosis].
Sun JJ; Yin LR; Mi RR; Ma HD; Guo SJ; Shi Y; Gu YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):45-50. PubMed ID: 20367926
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic agents are effective inhibitors of endometriosis.
Hull ML; Charnock-Jones DS; Chan CL; Bruner-Tran KL; Osteen KG; Tom BD; Fan TP; Smith SK
J Clin Endocrinol Metab; 2003 Jun; 88(6):2889-99. PubMed ID: 12788903
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive study of angiogenic factors in women with endometriosis compared to women without endometriosis.
Yerlikaya G; Balendran S; Pröstling K; Reischer T; Birner P; Wenzl R; Kuessel L; Streubel B; Husslein H
Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():88-98. PubMed ID: 27541444
[TBL] [Abstract][Full Text] [Related]
29. Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model.
Ercan CM; Kayaalp O; Cengiz M; Keskin U; Yumusak N; Aydogan U; Ide T; Ergun A
Arch Gynecol Obstet; 2015 May; 291(5):1103-11. PubMed ID: 25367601
[TBL] [Abstract][Full Text] [Related]
30. The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation.
Mariani M; Viganò P; Gentilini D; Camisa B; Caporizzo E; Di Lucia P; Monno A; Candiani M; Somigliana E; Panina-Bordignon P
Hum Reprod; 2012 Jul; 27(7):2010-9. PubMed ID: 22588001
[TBL] [Abstract][Full Text] [Related]
31. Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis.
Moggio A; Pittatore G; Cassoni P; Marchino GL; Revelli A; Bussolati B
Fertil Steril; 2012 Dec; 98(6):1521-30.e2. PubMed ID: 22981172
[TBL] [Abstract][Full Text] [Related]
32. A priori implantation potential does not differ in eutopic endometrium of patients with and without endometriosis.
Gescher DM; Siggelkow W; Meyhoefer-Malik A; Malik E
Arch Gynecol Obstet; 2005 Jul; 272(2):117-23. PubMed ID: 15986219
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Weill B; Batteux F; Chapron C
Fertil Steril; 2010 Oct; 94(5):1632-8.e1. PubMed ID: 20045515
[TBL] [Abstract][Full Text] [Related]
34. Effect of recombinant human endostatin on endometriosis in mice.
Jiang HQ; Li YL; Zou J
Chin Med J (Engl); 2007 Jul; 120(14):1241-6. PubMed ID: 17697575
[TBL] [Abstract][Full Text] [Related]
35. Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model.
Vlahos NF; Gregoriou O; Deliveliotou A; Perrea D; Vlachos A; Zhao Y; Lai J; Creatsas G
Fertil Steril; 2010 Mar; 93(4):1316-23. PubMed ID: 19147132
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
37. The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis.
Sanchez AM; Quattrone F; Pannese M; Ulisse A; Candiani M; Diaz-Alonso J; Velasco G; Panina-Bordignon P
Hum Reprod; 2017 Jan; 32(1):175-184. PubMed ID: 27821707
[TBL] [Abstract][Full Text] [Related]
38. [Expression of vascular endothelial growth factor in nude mouse models of human endometriosis].
Yang F; Ma Y; He YL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):816-9. PubMed ID: 18504210
[TBL] [Abstract][Full Text] [Related]
39. [Expression of vascular endothelial growth factor receptors in the ectopic and eutopic endometrium of women with endometriosis].
Wang HB; Lang JH; Leng JH; Zhu L; Liu ZF; Sun DW
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1555-9. PubMed ID: 16179118
[TBL] [Abstract][Full Text] [Related]
40. Thrombospondin-1 mimetic peptide ABT-898 affects neovascularization and survival of human endometriotic lesions in a mouse model.
Nakamura DS; Edwards AK; Virani S; Thomas R; Tayade C
Am J Pathol; 2012 Aug; 181(2):570-82. PubMed ID: 22727957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
